|

Selumetinib Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: AZD6244, Koselugo

Other1 trial

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
Phase 1/2

Birmingham, Alabama1 trial

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Childrens of Alabama

Phase 2

Chicago, Illinois1 trial

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

The University of Chicago

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.